Proximal superficial femoral artery puncture using an ascending approach for stent re-occlusion in the common femoral artery.
Endovascular treatment
Puncture site
Stent restenosis
Superficial femoral artery
Journal
Journal of cardiology cases
ISSN: 1878-5409
Titre abrégé: J Cardiol Cases
Pays: Japan
ID NLM: 101549579
Informations de publication
Date de publication:
May 2024
May 2024
Historique:
received:
05
09
2023
revised:
01
12
2023
accepted:
03
01
2024
medline:
5
8
2024
pubmed:
5
8
2024
entrez:
5
8
2024
Statut:
epublish
Résumé
We aimed to describe a technique for approaching the common femoral artery (CFA) in cases where doing so is difficult owing to an occluded lesion caused by a previously implanted stent. A 72-year-old woman had severe stenotic lesions in both iliac arteries that required an approach via the bilateral femoral arteries. The right CFA had a previously implanted stent and a completely occluded lesion that extended from the superficial femoral artery (SFA). A 20G needle was inserted through the proximal SFA, and the needle tip was advanced into the CFA stent and passed through the occluded lesion using a microcatheter and guide wire (GW). This allowed us to insert a guide catheter via the GW into the occluded lesion. No complications, such as bleeding, were observed after the procedure. When the CFA is occluded by a stent, an ascending approach through the proximal SFA is a viable treatment option. An occluded lesion due to a previously implanted stent makes approaching the common femoral artery difficult. Hence, alternative approaches are needed. In this regard, an approach via the proximal superficial femoral artery may prove useful.
Identifiants
pubmed: 39100512
doi: 10.1016/j.jccase.2024.01.003
pii: S1878-5409(24)00003-3
pmc: PMC11295016
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Pagination
205-208Informations de copyright
© 2024 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare that there is no conflict of interest.